Nuveen Asset Management, LLC Intra Cellular Therapies, Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 819,675 shares of ITCI stock, worth $56.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

819,675

Previous 881,031 6.96%

Holding current value

$56.2 Million

Previous $63.1 Million 10.11%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$64.37 - $75.65 $3.95 Million - $4.64 Million	-61,356 Reduced 6.96%	819,675 $56.7 Million
Q4 2023 Feb 14, 2024	BUY	$46.37 - $73.65 $7.78 Million - $12.4 Million	167,770 Added 23.52%	881,031 $63.1 Million
Q3 2023 Nov 14, 2023	SELL	$52.09 - $64.1 $12.8 Million - $15.8 Million	-246,679 Reduced 25.7%	713,261 $37.2 Million
Q2 2023 Aug 14, 2023	BUY	$54.67 - $66.44 $9.36 Million - $11.4 Million	171,276 Added 21.72%	959,940 $60.8 Million
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $2.28 Million - $2.96 Million	52,016 Added 7.06%	788,664 $42.7 Million

Q4 2022 Feb 14, 2023	BUY	$44.07 - $54.45 $7.84 Million - $9.69 Million	177,924 Added 31.84%	736,648 $39 Million
Q3 2022 Nov 14, 2022	SELL	$42.7 - $59.99 $3.41 Million - $4.79 Million	-79,874 Reduced 12.51%	558,724 $26 Million
Q2 2022 Aug 15, 2022	SELL	$43.0 - $65.64 $5.13 Million - $7.83 Million	-119,262 Reduced 15.74%	638,598 $36.5 Million
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $4.8 Million - $7.7 Million	123,973 Added 19.56%	757,860 $44.4 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $244,006 - $370,307	-6,932 Reduced 1.08%	633,887 $22.2 Million
Q3 2021 Nov 12, 2021	SELL	$28.72 - $42.49 $1.55 Million - $2.29 Million	-53,939 Reduced 7.76%	640,819 $23.9 Million
Q2 2021 Aug 16, 2021	SELL	$29.3 - $44.5 $1.96 Million - $2.98 Million	-67,000 Reduced 8.8%	694,758 $28.4 Million
Q1 2021 May 17, 2021	SELL	$30.8 - $39.51 $510,078 - $654,325	-16,561 Reduced 2.13%	761,758 $25.8 Million
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $296,814 - $409,741	-12,717 Reduced 1.61%	778,319 $24.8 Million
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $1.83 Million - $3.31 Million	104,018 Added 15.14%	791,036 $20.3 Million
Q2 2020 Aug 14, 2020	BUY	$14.35 - $26.64 $1.54 Million - $2.86 Million	107,525 Added 18.56%	687,018 $17.6 Million
Q1 2020 May 14, 2020	BUY	$12.31 - $33.12 $2.92 Million - $7.85 Million	236,929 Added 69.16%	579,493 $8.91 Million
Q4 2019 Feb 14, 2020	BUY	$7.26 - $38.49 $732,918 - $3.89 Million	100,953 Added 41.78%	342,564 $11.8 Million
Q3 2019 Nov 14, 2019	SELL	$7.47 - $14.03 $2.81 Million - $5.28 Million	-376,643 Reduced 60.92%	241,611 $1.81 Million
Q2 2019 Aug 15, 2019	BUY	$10.65 - $14.29 $6.58 Million - $8.83 Million	618,254 New	618,254 $8.02 Million

Others Institutions Holding ITCI

# of Institutions

381

Shares Held

77.7M

Call Options Held

1.7M

Put Options Held

1.13M

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $6.47B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Intra Cellular Therapies, Inc. Transaction History